Anaesthesia for Hip and Knee Arthroplasty (SPIGA)
SPIGA
Spinal Versus General Anaesthesia for Hip and Knee Arthroplasty. The Randomised, Clinical, Multicentre SPIGA Trial
1 other identifier
interventional
3,000
0 countries
N/A
Brief Summary
Beneficial and harmful effects of spinal versus general anaesthesia in patients undergoing hip and knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2026
CompletedFirst Posted
Study publicly available on registry
September 22, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2031
September 29, 2026
August 1, 2026
4.9 years
September 7, 2026
September 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital-free days within 30 days
Defined as the number of days within the first 30 days following hip or knee arthroplasty surgery during which a participant is alive and not admitted to a hospital.
Postoperative day 0-30
Secondary Outcomes (2)
Major complications
Postoperative day 0-30
Quality of Recovery
24 hours postoperatively
Other Outcomes (5)
Patient satisfaction with anaesthesia
24 hours postoperatively
Health-related quality of life (EQ5D5L-VAS)
Postoperative day 30
Number of unplanned hospital-visits
Postoperative day 0-30
- +2 more other outcomes
Study Arms (2)
Spinal Anaesthesia
EXPERIMENTALGeneral Anaesthesia
ACTIVE COMPARATORInterventions
Spinal anaesthesia according to local practice, including optional sedation with sedative-hypnotic pharmacological agents
Eligibility Criteria
You may qualify if:
- Scheduled for elective primary elective hip or knee arthroplasty, including unicompartmental knee
You may not qualify if:
- Scheduled for elective primary hip or knee arthroplasty, including unicompartmental knee
- Age ≥ 18 years
- Unable to communicate in written and/or spoken Danish Contraindications against either spinal or general anaesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Chair Professor
Study Record Dates
First Submitted
September 7, 2026
First Posted
September 22, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
September 1, 2031
Study Completion (Estimated)
September 1, 2031
Last Updated
September 29, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The study protocol and statistical analysis plan will be available after they have been published.
Data will be published anonymised in accordance with ICMJE (International Committee of Medical Journal Editors) guidelines.